Steven R. Whittaker
Publications by Year
Research Areas
Melanoma and MAPK Pathways, Colorectal Cancer Treatments and Studies, Computational Drug Discovery Methods, Cancer Mechanisms and Therapy, Protein Degradation and Inhibitors
Most-Cited Works
- → Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF(2010)1,455 cited
- → The Genetic Landscape of Clinical Resistance to RAF Inhibition in Metastatic Melanoma(2013)931 cited
- → The role of signaling pathways in the development and treatment of hepatocellular carcinoma(2010)822 cited
- → Inhibitors of cyclin-dependent kinases as cancer therapeutics(2017)367 cited
- → A Genome-Scale RNA Interference Screen Implicates NF1 Loss in Resistance to RAF Inhibition(2013)348 cited
- → Paradox-Breaking RAF Inhibitors that Also Target SRC Are Effective in Drug-Resistant BRAF Mutant Melanoma(2014)209 cited
- → The Cyclin-dependent Kinase Inhibitor CYC202 (R-Roscovitine) Inhibits Retinoblastoma Protein Phosphorylation, Causes Loss of Cyclin D1, and Activates the Mitogen-activated Protein Kinase Pathway(2004)193 cited
- → Gatekeeper Mutations Mediate Resistance to BRAF-Targeted Therapies(2010)155 cited
- → In vitro and In vivo Pharmacokinetic-Pharmacodynamic Relationships for the Trisubstituted Aminopurine Cyclin-Dependent Kinase Inhibitors Olomoucine, Bohemine and CYC202(2005)131 cited
- → Automated low flow pump system for the treatment of refractory ascites: A multi-center safety and efficacy study(2013)130 cited